Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Government Accountability Office. HIV/AIDS Drugs: Funding Implications of New Combination Therapies for Federal and State Programs. HEHS-99-2. Washington, DC, 1998. https://www.govinfo.gov/app/details/GAOREPORTS-HEHS-99-2
Health, Education, and Human Services Division, Government Accountability Office. (1998, October 14). GAO/HEHS-99-2 - HIV/AIDS Drugs: Funding Implications of New Combination Therapies for Federal and State Programs. [Government]. U.S. Government Printing Office. https://www.govinfo.gov/app/details/GAOREPORTS-HEHS-99-2
Health, Education, and Human Services Division, Government Accountability Office. GAO/HEHS-99-2 - HIV/AIDS Drugs: Funding Implications of New Combination Therapies for Federal and State Programs. U.S. Government Printing Office, (14 Oct 1998), https://www.govinfo.gov/app/details/GAOREPORTS-HEHS-99-2
Health, Education, and Human Services Division, Government Accountability Office, HIV/AIDS Drugs: Funding Implications of New Combination Therapies for Federal and State Programs, GovInfo, (October 14, 1998), https://www.govinfo.gov/app/details/GAOREPORTS-HEHS-99-2